Xirmada ogaanshaha ee Antigen ilaa Neefsashada Isku-xidhka Virus-ka Colloidal Gold
Xirmada ogaanshaha ee Antigen-ka ilaa Fayraska Isku-dhafka ah ee Neefsashada
Dahabka Colloidal
Macluumaadka wax soo saarka
| Nambarka Model | RSV-AG | Baakad | 25 Tijaabooyin/xirmo, 30kits/CTN |
| Magaca | Xirmada ogaanshaha ee Antigen-ka ilaa Fayraska isku-dhafka ah ee neefsiga Dahabka Colloidal | Kala soocidda qalabka | Fasalka I |
| Astaamaha | Dareen sare, hawl fudud | Shahaado | CE/ ISO13485 |
| Saxnaanta | > 99% | Nolosha shelf | Laba Sano |
| Habka | Dahabka Colloidal | OEM/ODM adeegga | La heli karo |
Habka tijaabada
| 1 | Qalabka tijaabada ka soo saar bacda aluminiumka, dul saar miis fidsan oo si sax ah u calaamadee muunada. |
| 2 | Ku dar 10ul oo serum ama muunad balasma ah ama 20ul oo dhiig ah dalool muunadda, ka dibna faleebo 100uL (qiyaastii 2-3 dhibcood) oo muunad ah oo lagu qasi karo god muunad oo bilow waqti. |
| 3 | Natiijada waa in lagu akhriyaa 10-15 daqiiqo gudahood.Natiijada imtixaanku waxay noqon doontaa mid aan shaqaynayn 15 daqiiqo ka dib. |
Fiiro gaar ah: muunad kasta waa in lagu shubaa pipette nadiif ah oo la tuuri karo si looga fogaado wasakheynta.
Isticmaalka damacsan
Reagent-kan waxa loo istcimaalaa ogaanshaha tayada ee vitro ee antigen ilaa fayraska syncytial neef-mareenka (RSV) ee suufka oropharyngeal bini aadamka iyo muunadaha suufka sanka ee nasopharyngeal, waxayna ku habboon tahay ogaanshaha kaaliyaha ee caabuqa fayraska syncytial neef-mareenka.Qalabkani waxa uu bixiyaa kaliya natiijada ogaanshaha antigen-ka ee fayraska syncytial ee neef-mareenka, natiijooyinka la helayna waa in lagu daro macluumaadka kale ee caafimaad ee falanqaynta.Waa in ay isticmaalaan kaliya xirfadlayaasha daryeelka caafimaadka.
Soo koobid
Fayraska syncytial neefsashada waa fayras RNA ah oo iska leh Pneumovirus, qoyska Pneumovirinae.Inta badan waxa lagu kala qaadaa gudbinta dhibcaha, iyo taabashada tooska ah ee farta uu wasakhaysan yahay fayraska syncytial ee neef-mareenka oo leh xuubka sanka iyo xuubka indhaha ayaa sidoo kale ah waddo muhiim ah oo la isugu gudbiyo.Fayraska syncytial neef-mareenka ayaa sabab u ah oof-wareen.Ka dib xilliga caabuqa, fayraska syncytial neef-mareenka wuxuu keeni doonaa qandho, sanka oo dareera, qufac iyo mararka qaarkood suuxdin.Infekshanka fayraska syncytial ee neefsashada ayaa laga yaabaa inuu ku dhex dhaco dadyowga kooxaha da' kasta, halkaasoo dadka waayeelka ah iyo dadka qaba sambabada, wadnaha ama habka difaaca ay u badan tahay inay qaadaan cudurka.
Tilmaam:
• xasaasi sare
• natiijada akhriska 15 daqiiqo gudahood
• Hawlgal fudud
• Qiimaha tooska ah ee warshadda
Uma baahnid mishiin dheeri ah si aad natiijada u akhrido
Akhrinta natiijada
Tijaabada reagent WIZ BIOTECH waxa la barbar dhigi doonaa reagent-ka kantaroolka:
| Natiijada tijaabada wiz | Natiijooyinka tijaabada ee reajentiyeyaasha tixraaca | Heerka shil ee togan:74.03% (95%CI67.19%~79.87%)Heerka shilka xun:99.22%(95%CI97.73%~99.73%)Wadarta heerka u hoggaansanaanta:99.29% (95%CI88.52%~93.22%) | ||
| Wanagsan | xun | Wadarta | ||
| Wanagsan | 134 | 3 | 137 | |
| xun | 47 | 381 | 428 | |
| Wadarta | 181 | 384 | 565 | |
Akhrinta natiijada
Tijaabada reagent WIZ BIOTECH waxa la barbar dhigi doonaa reagent-ka kantaroolka:
| Natiijada tijaabada wiz | Natiijooyinka tijaabada ee reajentiyeyaasha tixraaca | Heerka shil ee togan:74.03% (95%CI67.19%~79.87%)Heerka shilka xun:99.22%(95%CI97.73%~99.73%)Wadarta heerka u hoggaansanaanta:99.29% (95%CI88.52%~93.22%) | ||
| Wanagsan | xun | Wadarta | ||
| Wanagsan | 134 | 3 | 137 | |
| xun | 47 | 381 | 428 | |
| Wadarta | 181 | 384 | 565 | |
Waxa kale oo aad jeclaan kartaa:
HIV
Xirmada ogaanshaha ee ka-hortagga unugyada difaaca jidhka ee fayraska HIV-ga Dahabka Kolloidhka ah
-
Qalabka ogaanshaha ee borotiinka C-reactive/serum amy...
-
Xirmada ogaanshaha ee IgM Antibody ilaa Mycoplasma P...
-
Xirmada ogaanshaha ee IgM Antibody to Enterovirus ...
-
Xirmada ogaanshaha IgM Antibody to C Pneumoniae...
-
Xirmada ogaanshaha ee Anibody ilaa Treponema Pallidu...
-
Ogaanshaha caabuqa Duumada PF PV Tijaabada Degdega ah ee Co...
